Defunct Company
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
69
NCT01041235
Safety Study of a Liposomal Docetaxel Formulation in Patients With Solid Tumors Who Have Failed Previous Therapies
Phase: Phase 1
Role: Lead Sponsor
Start: Dec 31, 2009
Completion: Dec 31, 2011
NCT01715168
A Crossover Bioequivalence Study of Intravenously Administered ATI0918 and DOXIL/CAELYX in Patients With Ovarian Cancer
Start: Oct 31, 2012
Completion: Dec 31, 2015